Article info

Original research
Phase 1 open-label trial of intravenous administration of MVA-BN-brachyury-TRICOM vaccine in patients with advanced cancer

Authors

  1. Correspondence to Dr Marijo Bilusic; marijo.bilusic{at}nih.gov
View Full Text

Citation

DeMaria PJ, Lee-Wisdom K, Donahue RN, et al
Phase 1 open-label trial of intravenous administration of MVA-BN-brachyury-TRICOM vaccine in patients with advanced cancer

Publication history

  • Accepted July 8, 2021
  • First published September 3, 2021.
Online issue publication 
September 03, 2021
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.